Anterix (ATEX) Cost of Revenue (2013 - 2021)

Anterix (ATEX) has 9 years of Cost of Revenue data on file, last reported at $5000.0 in Q4 2021.

• Quarterly Cost of Revenue fell 99.08% year-over-year to $5000.0 in Q4 2021, while the trailing twelve-month figure through Mar 2023 was $5000.0 (down 99.09% YoY) and the FY2022 annual result came in at $5000.0, down 99.69% from the prior year.
• Cost of Revenue eased to $5000.0 in Q4 2021, from $543000.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $2.3 million in Q1 2018 to a low of $5000.0 in Q4 2021.
• A 5-year average of $1.2 million and a median of $974000.0 in 2018 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2018 — Cost of Revenue gained 26.24% — and 2021, when it plunged 99.08%.
• Tracing ATEX's Cost of Revenue over 5 years: stood at $2.0 million in 2017, then plunged by 51.69% to $974000.0 in 2018, then sank by 35.22% to $631000.0 in 2019, then fell by 13.95% to $543000.0 in 2020, then sank by 99.08% to $5000.0 in 2021.
• The last three Cost of Revenue figures came in at $5000.0 (Q4 2021), $543000.0 (Q4 2020), and $515000.0 (Q3 2020), per Business Quant data.